| dc.contributor.author | Demirkan, Serkan | |
| dc.date.accessioned | 2020-06-25T18:34:23Z | |
| dc.date.available | 2020-06-25T18:34:23Z | |
| dc.date.issued | 2019 | |
| dc.identifier.citation | closedAccess | en_US |
| dc.identifier.issn | 1476-4172 | |
| dc.identifier.issn | 1476-4180 | |
| dc.identifier.uri | https://doi.org/10.1080/14764172.2018.1427873 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12587/7888 | |
| dc.description | WOS: 000457033100003 | en_US |
| dc.description | PubMed: 29469597 | en_US |
| dc.description.abstract | Eccrine hidrocystomes (EH) are benign cystic tumors of dermal eccrine ducts. There is still no gold standard treatment option for EH because of the large number of lesions, the risk of cicatrization and the different treatment options offered. We offer combined oral isotretinoin and following erbium-yttrium aluminum garnet laser treatment as an alternative treatment option in difficult patients with EH. | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Taylor & Francis Inc | en_US |
| dc.relation.isversionof | 10.1080/14764172.2018.1427873 | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Lasers and light sources | en_US |
| dc.subject | erbium-yttrium aluminum garnet laser | en_US |
| dc.subject | isotretinoin | en_US |
| dc.subject | eccrine hidrocystoma | en_US |
| dc.title | Treatment of multiple eccrine hidrocystoma with oral isotretinoin following erbium-yttrium aluminum garnet laser | en_US |
| dc.type | article | en_US |
| dc.contributor.department | Kırıkkale Üniversitesi | en_US |
| dc.identifier.volume | 21 | en_US |
| dc.identifier.issue | 1 | en_US |
| dc.identifier.startpage | 11 | en_US |
| dc.identifier.endpage | 13 | en_US |
| dc.relation.journal | Journal Of Cosmetic And Laser Therapy | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
